Las Vegas, NV -- (SBWIRE) -- 08/31/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Generex Biotechnology Corporation (OTCMKTS:GNBT), Titan Pharmaceuticals, Inc. (OTCBB:TTNP), GelTech Solutions, Inc. (OTCMKTS:GLTC), International Stem Cell Corp (OTCMKTS:ISCO)
Generex Biotechnology Corporation (OTCMKTS:GNBT) declined -2.44%, trading on 796,934 shares, to end the trade at $0.0320. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.02 and was moved to the maximum level of $0.09. The stock changed hands in a range of $0.03 to $0.03, bringing its market capitalization to about $16.03 million. Generex Biotechnology Corporation (www.generex.com) (GNBT) announced publication of follow up studies from a Phase I clinical trial of its immunotherapeutic agent AE37 in patients with prostate cancer. The Phase I study demonstrated that the compound is safe, well-tolerated, and generated a specific and robust immune response.
Has GNBT Found The Bottom and Ready To Move Up? Find Out Here
Titan Pharmaceuticals, Inc. (OTCBB:TTNP) declined -1.93%, to complete the trading session at $0.598, with a total volume of 75,559 shares. The stock, on average, trades on a volume of 202,733 shares. In the past 52 weeks, the share price has not declined below $0.32 and above $2.53. It floated in a range of $0.58 to $0.61 during the last trading session, with a beta value of 9.69. Its market capitalization now moved to about $49.38million. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States. The company offers Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia.
Has TTNP Found The Bottom And Ready To Gain Momentum? Find Out Here
GelTech Solutions, Inc. (OTCMKTS:GLTC) recorded a fall of -8.09% and was in a range of $1.25-$1.42 before closing at $1.25. The share price hit its 52-week low of $0.21 and $1.75 was the best price. The stock completed the day with a total volume of 19,646 shares, versus an average volume of 36,292 shares. GelTech Solutions, Inc. engages in the development and marketing of environmentally friendly products in the United States and internationally. It primarily offers FireIce, a fire suppression and fire retardant product; FireIce HDU, a home defense unit that enables homeowners to apply FireIce to protect homes from advancing wildfires; Soil2O ? Dust Control, a dust control product; and Soil2O, a line of agricultural moisture retention products.
Will GLTC Bounce Back After yesterday’s Sharp Sell off? Find Out Here
International Stem Cell Corp (OTCMKTS:ISCO) yesterday, bringing its market capitalization around $19.23 million. The total number of shares that changed hands during the session was 35,824 shares, as compared to average trading volume of 651,077 shares. The share price, after opening at $0.14, made a high of $0.15 and hovered above $0.14 to end the day at $0.145. International Stem Cell Corporation (ISCO) (www.internationalstemcell.com) a California-based biotechnology company developing novel stem cell-based therapies, announced that it has entered into a master clinical research agreement with Duke University to conduct clinical trials research in Parkinson's disease using ISCO's innovative neural stem cell product.
Can Investors Bet on ISCO after this News update? Find out in this Research Report
About Value Penny Stocks
Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks.
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)